Journal article
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Abstract
AIMS: The prevalence and importance of liver function test (LFT) abnormalities in a large contemporary cohort of heart failure patients have not been systematically evaluated.
METHODS AND RESULTS: We characterized the LFTs of 2679 patients with symptomatic chronic heart failure from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity program (CHARM). We used multivariable modelling to assess the relationships …
Authors
Allen LA; Felker GM; Pocock S; McMurray JJV; Pfeffer MA; Swedberg K; Wang D; Yusuf S; Michelson EL; Granger CB
Journal
European Journal of Heart Failure, Vol. 11, No. 2, pp. 170–177
Publisher
Wiley
Publication Date
2 2009
DOI
10.1093/eurjhf/hfn031
ISSN
1388-9842